ContraFect Corporation is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for the treatment of infectious diseases, including those caused by drug-resistant pathogens.

Biotechnology

ContraFect

Roger J. Pomerantz

Marina Bass, CPA

Keren Marshal

Brittany La

Abraham Thariath

Gary Woodnutt

Matthew Salamone

Jane E. Ambler

Nancy Capra

The executive team at ContraFect has a history of working in finance and accounting. The team has experience working at Lexicon Pharmaceuticals, Coelacanth Corporation, and Ernst & Young. They have also received education from top universities.

CEO and Executive Team

Leadership Team

Board of Directors

CEO and Executive Team

About

Team members

Other teams at ContraFect

Leadership Team

Board of Directors